Comments on 'Evaluating the safety and efficacy of biologics in psoriatic patients with malignancies: Insights and future directions'

J Eur Acad Dermatol Venereol. 2025 Feb;39(2):e193-e194. doi: 10.1111/jdv.20246. Epub 2024 Jul 14.

Authors

M Magnano¹, G Rech¹, R Balestri¹

Affiliation

¹ Division of Dermatology, Psoriasis Outpatient Service, Trento Hospital, APSS, Trento, Italy.

PMID: 39005004
DOI: 10.1111/jdv.20246

No abstract available

Publication types

Letter